Genetic and environmental influences on total plasma homocysteine and coronary artery disease (CAD) risk among South Indians

Clinica Chimica Acta

Volumn 405, Issue 1-2, 2009, Pages 127-131

  Vinukonda, Govindaiah ^a   Shaik Mohammad, Naushad ^b   Md Nurul Jain, Jamal ^b   Prasad Chintakindi, Krishna ^b   Rama Devi Akella, Radha ^b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Center for DNA Fingerprinting and Diagnostics   (India)

Author keywords

5 methyl tetrahydrofolate homocysteine methyl transferase; Coronary artery disease; Glutamate carboxypeptidase II; Homocysteine; Methionine synthase reductase; Methylene tetrahydrofolate reductase

Indexed keywords

5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CREATININE; FOLIC ACID; GLUTAMATE CARBOXYPEPTIDASE II; HOMOCYSTEINE; METHIONINE SYNTHASE REDUCTASE;

ADULT; AGED; ALCOHOL CONSUMPTION; AMINO ACID BLOOD LEVEL; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ENVIRONMENTAL FACTOR; FEMALE; GENETIC POLYMORPHISM; HEREDITY; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RISK ASSESSMENT; SEX DIFFERENCE;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; ADULT; AGED; ALLELES; CORONARY DISEASE; FEMALE; FERREDOXIN-NADP REDUCTASE; GENOTYPE; GLUTAMATE CARBOXYPEPTIDASE II; HOMOCYSTEINE; HUMANS; INDIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 67349124844     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.04.015     Document Type: Article

References (42)

1. Ahmad N., and Bhopal R. Is coronary heart disease rising in India? A systematic review based on ECG defined coronary heart disease. Heart 91 (2005) 719-725
2. Singh R.B., Sharma J.P., Rastogi V., et al. Prevalence of coronary artery disease and coronary risk factors in rural and urban populations of north India. Eur Heart J 18 (1997) 1728-1735
3. Mayer E.L., Jacobsen D.W., and Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 27 (1996) 517-527
4. Welch G.N., and Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 338 (1998) 1042-1050
5. Refsum H., Yajnik C.S., Gadkari M., et al. Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am J Clin Nutr 74 (2001) 233-241
6. Tyagi N., Sedoris K.C., Steed M., Ovechkin A.V., Moshal K.S., and Tyagi S.C. Mechanisms of homocysteine-induced oxidative stress. Am J Physiol Heart Circ Physiol 289 (2005) H2649-H2656
7. Voutilainen S., Morrow J.D., and Roberts II L.J. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol 19 (1999) 1263-1266
8. Blundell G., Jones B.G., Rose F.A., and Tudball N. Homocysteine mediated endothelial cell toxicity and its amelioration. Atherosclerosis 122 (1996) 163-172
9. Nishio E., and Watanabe Y. Homocysteine as a modulator of platelet-derived growth factor action in vascular smooth muscle cells: a possible role for hydrogen peroxide. Br J Pharmacol 122 (1997) 269-274
10. Jiang Y., Jiang J., and Xiong J. Homocysteine-induced extracellular superoxide dismutase and its epigenetic mechanisms in monocytes. J Exp Biol 211 Pt 6 (2008) 911-920
11. Devlin M., Ling E.H., and Peerson J.M. Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia. Hum Mol Genet 9 (2000) 2837-2844
12. Girelli D., Martinelli N., and Pizzolo F. The interaction between MTHFR 677C → T genotype and folate status is a determinant of coronary atherosclerosis risk. J Nutr 133 (2003) 1281-1285
13. Gaughan D.J., Kluijtmans L.A., and Barbaux S. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 157 2 (Aug 2001) 451-456
14. Feix A., Winkelmayer W.C., Eberle C., Sunder-Plassmann G., and Födinger M. Methionine synthase reductase MTRR 66A > G has no effect on total homocysteine, folate, and Vitamin B12 concentrations in renal transplant patients. Atherosclerosis 174 (2004) 43-48
15. Brilakis E.S., Berger P.B., Ballman K.V., and Rozen R. Methylenetetrahydrofolate reductase (MTHFR) 677C > T and methionine synthase reductase (MTRR) 66A > G polymorphisms: association with serum homocysteine and angiographic coronary artery disease in the era of flour products fortified with folic acid. Atherosclerosis 168 (2003) 315-322
16. Brown C.A., McKinney K.Q., Kaufman J.S., Gravel R.A., and Rozen R. A common polymorphism in methionine synthase reductase increases risk of premature coronary artery disease. J Cardiovasc Risk 7 (2000) 197-200
17. Laraqui A., Allami A., Carrie A., et al. Influence of methionine synthase (A2756G) and methionine synthase reductase (A66G) polymorphisms on plasma homocysteine levels and relation to risk of coronary artery disease. Acta Cardiol 61 (2006) 51-61
18. Alam M.A., Husain S.A., Narang R., Chauhan S.S., Kabra M., and Vasisht S. Association of polymorphism in the thermolabile 5, 10-methylene tetrahydrofolate reductase gene and hyperhomocysteinemia with coronary artery disease. Mol Cell Biochem 310 (2008) 111-117
19. Gopalan C, Rama Sastri BV, Balasubramanian SC. Nutritive value of Indian Foods. National Institute of Nutrition, Indian Council of Medical Research, Hyderabad, 1996; pp 47-91.
20. Puri A., Gupta O.K., Dwivedi R.N., Bharadwaj R.P., Narain V.S., and Singh S. Homocysteine and lipid levels in young patients with coronary artery disease. J Assoc Phys India 51 (2003) 681-685
21. Snehalatha C., Ramachandran A., Satyavani K., Sivasankari S., Sathyamurthy I., and Viswanathan V. Plasma homocysteine concentration and coronary artery disease in Asian Indians. J Assoc Phys India 50 (2002) 1229-1231
22. Pandey S.N., Vaidya A.D., Vaidya R.A., and Talwalkar S. Hyperhomocysteinemia as a cardiovascular risk factor in Indian women: determinants and directionality. J Assoc Phys India 54 (2006) 769-774
23. Wald D.S., Law M., and Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325 7374 (Nov 23 2002) 1202
24. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288 (2002) 2015-2022
25. Mukherjee M., Joshi S., Bagadi S., Dalvi M., Rao A., and Shetty K.R. A low prevalence of the C677T mutation in the methylenetetrahydrofolate reductase gene in Asian Indians. Clin Genet 61 (2002) 155-159
26. Chambers J.C., Ireland H., and Thompson E. Methylene tetrahydrofolate reductase 677 C-- > T mutation and coronary heart disease risk in UK Indian Asians. Arterioscler Thromb Vasc Biol 20 (2000) 2448-2452
27. Lewis S.J., Ebrahim S., and Davey Smith G. Meta-analysis of MTHFR 677C- > T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?. BMJ 331 7524 (2005) 1053
28. Urreizti R., Asteggiano C., Vilaseca M.A., et al. A CBS haplotype and a polymorphism at the MSR gene are associated with cardiovascular disease in a Spanish case-control study. Clin Biochem 40 (2007) 864-868 Electronic publication 2007 Apr 27
29. Neela J., and Raman L. The relationship between maternal nutritional status and spontaneous abortion. Natl Med J India 10 (1997) 15-16
30. Refsum H., Yajnik C.S., and Gadkari M. Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am J Clin Nutr 74 (2001) 233-241
31. Guéant-Rodriguez R.M., Juilliére Y., and Candito M. Association of MTRRA66G polymorphism (but not of MTHFR C677T and A1298C, MTRA2756G, TCN C776G) with homocysteine and coronary artery disease in the French population. Thromb Haemost 94 (2005) 510-515
32. Brilakis E.S., Berger P.B., Ballman K.V., and Rozen R. Methylenetetrahydrofolate reductase (MTHFR) 677C > T and methionine synthase reductase (MTRR) 66A > G polymorphisms: association with serum homocysteine and angiographic coronary artery disease in the era of flour products fortified with folic acid. Atherosclerosis 168 (2003) 315-322
33. Botto N., Andreassi M.G., and Manfredi S. Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage. Eur J Hum Genet 11 (2003) 671-678
34. Kim M.H., Kim E., Passen E.L., Meyer J., and Kang S.S. Cortisol and estradiol: nongenetic factors for hyperhomocyst(e)inemia. Metabolism 46 (1997) 247-249
35. Brattström L., Lindgren A., Israelsson B., Andersson A., and Hultberg B. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med. 236 (1994) 633-641
36. Fukagawa N.K., Martin J.M., Wurthmann A., Prue A.H., Ebenstein D., and O'Rourke B. Sex-related differences in methionine metabolism and plasma homocysteine concentrations. Am J Clin Nutr. 72 (2000) 22-29
37. Halsted C.H., Villanueva J.A., Devlin A.M., and Chandler C.J. Metabolic interactions of alcohol and folate. J Nutr 132 (2002) 2367S-2372S
38. Barak A.J., Beckenhauer H.C., Tuma D.J., and Badakhsh S. Effects of prolonged ethanol feeding on methionine metabolism in rat liver. Biochem Cell Biol 65 (1987) 230-233
39. Barak A.J., Beckenhauer H.C., Hidiroglou N., Camilo M.E., Selhub J., and Tuma D.J. The relationship of ethanol feeding to the methyl folate trap. Alcohol 10 (1993) 495-497
40. Gabriel H.E., Crott J.W., and Ghandour H. Chronic cigarette smoking is associated with diminished folate status, altered folate form distribution, and increased genetic damage in the buccal mucosa of healthy adults. Am J Clin Nutr 83 4 (2006) 835-841
41. Emoto M., Kanda H., and Shoji T. Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes Care 24 (2001) 533-538
42. Hoogeven E., Kostense P., Jakobs C., Bouter L., Heine R., and Stehouwer C. Does metformin increase the serum total homocysteine level in non insulin dependent diabetes mellitus?. J Intern Med 242 (1997) 389-394